Technical Analysis for ENZ - Enzo Biochem, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.13 | -1.74% | -0.02 |
Earnings due: Nov 4
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Flat | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Fell Below 50 DMA | Bearish | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Gapped Down | Weakness | 0.00% | |
200 DMA Resistance | Bearish | -1.74% | |
20 DMA Support | Bullish | -1.74% |
Alert | Time |
---|---|
Possible Inside Day | about 19 hours ago |
Gap Up Closed | about 23 hours ago |
Gap Up Partially Closed | about 23 hours ago |
Reversed from Up | about 23 hours ago |
Gap Down Partially Closed | about 23 hours ago |
Get a Trading Assistant
- Earnings date: 11/04/2024
Enzo Biochem, Inc. Description
Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory, a network of approximately 30 patient service centers, a laboratory, and a full-service phlebotomy and in-house logistics department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It provides proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which offer tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts primarily in the field of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment researches and develops therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company sells its products through its direct sales force; and a network of distributors worldwide. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Acid Diabetes Autoimmune Disease Antibodies Molecular Biology Gastrointestinal Drug Development Clinical Research Cardiovascular Disease Obesity Neurological Disorders Ophthalmic Genetic Engineering Lab Testing Metabolic Disease Gene Expression Peptides Urological Disorders Dyes Medical Laboratory Search Products Biochemistry Research Products Endocrine Disorders Medical Diagnosis Diagnostic And Research Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.5 |
52 Week Low | 0.9901 |
Average Volume | 59,535 |
200-Day Moving Average | 1.17 |
50-Day Moving Average | 1.13 |
20-Day Moving Average | 1.14 |
10-Day Moving Average | 1.14 |
Average True Range | 0.04 |
RSI (14) | 47.92 |
ADX | 21.63 |
+DI | 18.41 |
-DI | 12.41 |
Chandelier Exit (Long, 3 ATRs) | 1.08 |
Chandelier Exit (Short, 3 ATRs) | 1.22 |
Upper Bollinger Bands | 1.16 |
Lower Bollinger Band | 1.11 |
Percent B (%b) | 0.34 |
BandWidth | 3.99 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0007 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.18 | ||||
Resistance 3 (R3) | 1.18 | 1.17 | 1.17 | ||
Resistance 2 (R2) | 1.17 | 1.16 | 1.17 | 1.16 | |
Resistance 1 (R1) | 1.15 | 1.15 | 1.15 | 1.15 | 1.16 |
Pivot Point | 1.14 | 1.14 | 1.14 | 1.14 | 1.14 |
Support 1 (S1) | 1.12 | 1.13 | 1.12 | 1.12 | 1.10 |
Support 2 (S2) | 1.11 | 1.12 | 1.11 | 1.10 | |
Support 3 (S3) | 1.09 | 1.11 | 1.09 | ||
Support 4 (S4) | 1.09 |